Restricts establishment of mandates to become vaccinated against coronavirus disease 2019 (COVID-19); establishes reimbursement program to cover certain out-of-pocket costs incurred in obtaining COVID-19 vaccine.
Impact
The bill aims to address concerns surrounding the rapid development and approval of COVID-19 vaccines, which some argue are not sufficiently vetted for long-term safety. Its proponents believe that without a thorough record of the vaccines' effects, mandatory vaccinations should be limited to specific health care settings, where the risk profile and necessity are more clearly defined. This approach may influence how vaccinations are viewed in terms of public health policy and individual rights in New Jersey.
Summary
Bill A775 introduces restrictions on any mandates for immunization against SARS-CoV-2, the virus responsible for COVID-19. Specifically, the bill prohibits state, county, and local government entities, as well as educational institutions, from requiring individuals to receive such vaccinations. However, it maintains exceptions for health care workers in licensed facilities who interact with medically-vulnerable populations, thus ensuring that this segment can still be mandated to vaccinate in accordance with existing laws and policies.
Contention
A key point of contention lies in the balance between public health and individual rights. Supporters of the bill argue it protects individuals from potentially coercive vaccination mandates, especially given the controversial nature of COVID-19 vaccination. On the other hand, opponents may assert that such restrictions could undermine public health efforts, especially in protecting vulnerable populations who may be at higher risk without universal vaccination approaches.
Same As
Restricts establishment of mandates to become vaccinated against coronavirus disease 2019 (COVID-19); establishes reimbursement program to cover certain out-of-pocket costs incurred in obtaining COVID-19 vaccine.
Restricts establishment of mandates to become vaccinated against coronavirus disease 2019 (COVID-19); establishes reimbursement program to cover certain out-of-pocket costs incurred in obtaining COVID-19 vaccine.
Requires entities to accept confirmation of prior COVID-19 infection or protective immune response against COVID-19 when proof of vaccination is required.
Establishes criminal penalties for production, sale, and use of false COVID-19 vaccination verification card; requires AG to establish COVID-19 vaccination fraud prevention program.